Correlation between KRAS Mutation and CTLA-4 mRNA Expression in Circulating Tumour Cells: Clinical Implications in Colorectal Cancer

Combination strategies of KRAS inhibition with immunotherapy in treating advanced or recurrent colorectal carcinoma (CRC) may need to be assessed in circulating tumour cells (CTCs) to achieve better clinical outcomes. This study aimed to investigate the genomic variations of KRAS in CTCs and matched...

Descripción completa

Detalles Bibliográficos
Autores principales: Aktar, Sharmin, Islam, Farhadul, Cheng, Tracie, Gamage, Sujani Madhurika Kodagoda, Choudhury, Indra Neil, Islam, Md Sajedul, Lu, Cu Tai, Hamid, Faysal Bin, Ishida, Hirotaka, Abe, Ichiro, Xie, Nan, Gopalan, Vinod, Lam, Alfred K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530465/
https://www.ncbi.nlm.nih.gov/pubmed/37761948
http://dx.doi.org/10.3390/genes14091808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530465/
https://www.ncbi.nlm.nih.gov/pubmed/37761948
http://dx.doi.org/10.3390/genes14091808

Ejemplares similares